Literature DB >> 28516469

Doxycycline as an anti-inflammatory agent: updates in dermatology.

M Henehan1, M Montuno1, A De Benedetto1.   

Abstract

Doxycycline, a tetracycline antibiotic, is widely used in the field of dermatology for its antibiotic properties, anti-inflammatory properties and good safety profile. Over the past decades, numerous studies have clarified some of the anti-inflammatory mechanisms of doxycycline. In this review article, we aimed to provide an update on recent data on the anti-inflammatory properties of doxycycline and its potential role in cutaneous inflammatory diseases. Better understanding of these mechanisms might offer the practicing clinicians a better use of this therapeutic tool. In addition, research in this field could help clarify pathogenic aspects of inflammatory dermatologic diseases responsive to this medication. Further research is needed to fully elucidate the potential of doxycycline as an anti-inflammatory agent, and the development of new topical vehicles could open ways to new therapeutic possibilities for dermatologists.
© 2017 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28516469     DOI: 10.1111/jdv.14345

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  26 in total

1.  Evaluation of a Pasteurella multocida Respiratory Disease Induction Model for Goats (Capra aegagrus hircus).

Authors:  Joe S Smith; Jonathan P Mochel; Yeon-Jung Seo; Amanda P Ahrens; Ronald W Griffith
Journal:  Comp Med       Date:  2020-09-09       Impact factor: 0.982

Review 2.  Review of the Applications of Biomedical Compositions Containing Hydroxyapatite and Collagen Modified by Bioactive Components.

Authors:  Agnieszka Sobczak-Kupiec; Anna Drabczyk; Wioletta Florkiewicz; Magdalena Głąb; Sonia Kudłacik-Kramarczyk; Dagmara Słota; Agnieszka Tomala; Bożena Tyliszczak
Journal:  Materials (Basel)       Date:  2021-04-21       Impact factor: 3.623

3.  Efficacy and safety of tetracyclines for pemphigoid: a systematic review and meta-analysis.

Authors:  Xin-Xing Jin; Xue Wang; Ying Shan; Si-Zhe Li; Qun Xu; Hong-Zhong Jin; Ya-Gang Zuo
Journal:  Arch Dermatol Res       Date:  2021-03-28       Impact factor: 3.017

4.  Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial.

Authors:  Yuan Pan; Yu-Xi Chen; Jian Zhang; Miao-Li Lin; Guang-Ming Liu; Xue-Liang Xu; Xian-Qun Fan; Yong Zhong; Qing Li; Si-Ming Ai; Wen Xu; Jia Tan; Hui-Fang Zhou; Dong-Dong Xu; Hui-Ying Zhang; Bei Xu; Sha Wang; Jun-Jie Ma; Shuo Zhang; Lin-Yang Gan; Jian-Tao Cui; Li Li; Yan-Yan Xie; Xinxing Guo; Nathan Pan-Doh; Zhuo-Ting Zhu; Yao Lu; Yu-Xun Shi; Yi-Wen Xia; Zuo-Yi Li; Dan Liang
Journal:  JAMA Ophthalmol       Date:  2022-09-29       Impact factor: 8.253

5.  Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis.

Authors:  Mary Bohannon; Mingjin Liu; Peter Nadeau; Judy Talton; Daniel Gibson; Susmita Datta; Gregory Schultz; James Talton; Anna De Benedetto
Journal:  Exp Dermatol       Date:  2020-10-15       Impact factor: 3.960

Review 6.  A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

Authors:  Katerina Svigos; Lu Yin; Lauren Fried; Kristen Lo Sicco; Jerry Shapiro
Journal:  Am J Clin Dermatol       Date:  2021-08-04       Impact factor: 7.403

7.  Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial.

Authors:  Reaz Mahmud; Md Mujibur Rahman; Iftikher Alam; Kazi Gias Uddin Ahmed; A K M Humayon Kabir; S K Jakaria Been Sayeed; Mohammad Aftab Rassel; Farhana Binte Monayem; Md Shahidul Islam; Mohammad Monirul Islam; Anindita Das Barshan; Mohammad Mahfuzul Hoque; Md Uzzal Mallik; Mohammad Abdullah Yusuf; Mohammad Zaid Hossain
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 8.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

Authors:  Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern
Journal:  Allergy       Date:  2021-09-15       Impact factor: 14.710

9.  Doxycycline host-directed therapy in human pulmonary tuberculosis.

Authors:  Qing Hao Miow; Andres F Vallejo; Yu Wang; Jia Mei Hong; Chen Bai; Felicia Sw Teo; Alvin Dy Wang; Hong Rong Loh; Tuan Zea Tan; Ying Ding; Hoi Wah She; Suay Hong Gan; Nicholas I Paton; Josephine Lum; Alicia Tay; Cynthia Be Chee; Paul A Tambyah; Marta E Polak; Yee Tang Wang; Amit Singhal; Paul T Elkington; Jon S Friedland; Catherine Wm Ong
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

Review 10.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.